NYSE · PM
Consumer Defensive · Tobacco
$191.50
Down-$1.32 (-0.69%)
Updated Sep 25, 2026, 7:54 PM
SID Score
7.1/10
Composite research score
Smart Money
58/100
Neutral
Price performance
1M range · 20 trading sessions · Daily adjusted prices
PM closed at $191.50 after 20 trading sessions, up 0.54% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 24, 2026 | $192.41 | $194.71 | $191.14 | $191.50 | 3.15M |
| Sep 23, 2026 | $190.05 | $193.00 | $188.55 | $190.84 | 7.31M |
| Sep 22, 2026 | $188.46 | $191.953 | $186.695 | $190.23 | 7.81M |
| Sep 21, 2026 | $188.00 | $188.48 | $185.84 | $187.48 | 5.7M |
| Sep 18, 2026 | $188.00 | $191.00 | $186.56 | $188.62 | 7.81M |
| Sep 17, 2026 | $192.795 | $192.795 | $188.695 | $190.48 | 3.01M |
| Sep 16, 2026 | $192.42 | $195.49 | $191.54 | $191.71 | 2.93M |
| Sep 15, 2026 | $192.91 | $195.225 | $190.794 | $194.11 | 4.18M |
| Sep 14, 2026 | $195.19 | $195.35 | $192.85 | $194.86 | 2.94M |
| Sep 11, 2026 | $191.34 | $194.82 | $190.555 | $191.06 | 5.32M |
| Sep 10, 2026 | $188.61 | $192.445 | $188.4158 | $189.77 | 4.66M |
| Sep 9, 2026 | $185.50 | $186.28 | $181.55 | $185.71 | 3.95M |
| Sep 8, 2026 | $181.01 | $187.36 | $181.01 | $184.73 | 4.83M |
| Sep 4, 2026 | $185.03 | $185.9711 | $182.23 | $182.53 | 3.16M |
| Sep 3, 2026 | $188.65 | $189.085 | $186.065 | $186.17 | 2.76M |
| Sep 2, 2026 | $187.36 | $189.21 | $184.75 | $187.94 | 2.94M |
| Sep 1, 2026 | $190.35 | $192.3709 | $187.07 | $187.15 | 4.13M |
| Aug 31, 2026 | $190.78 | $191.00 | $186.99 | $187.30 | 4.01M |
| Aug 28, 2026 | $191.15 | $192.8528 | $190.20 | $191.89 | 3.82M |
| Aug 27, 2026 | $191.89 | $193.635 | $190.16 | $190.48 | 3.98M |
The latest Smart Investors Daily articles mentioning PM.
PM research
Company profile and research snapshot.
Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heat sticks, vapes, and oral nicotine offerings, primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI is not only dominant in smokable products but also has the Iqos and Zyn brands, which respectively dominate heated tobacco and nicotine pouches in most markets.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 23, 2026 | UBS | Neutral | — |
| Jul 30, 2026 | Citigroup | Buy | — |
| Jul 29, 2026 | Barclays | Overweight | — |
| Jul 23, 2026 | Morgan Stanley | Overweight | — |
| Jul 23, 2026 | Stifel | Buy | — |
Generated Sep 25, 2026, 5:20 PM
Philip Morris International fell 1.12% today as investors digest mixed signals from regulatory developments and company actions. While PM announced an impressive 8.8% dividend increase and benefits from potential FDA streamlining of vape approvals, concerns about the incoming Trump administration's regulatory approach and broader market headwinds are creating near-term pressure.
Bottom line: Philip Morris faces a binary regulatory environment where potential FDA streamlining of smoke-free product approvals could be highly accretive, but heightened scrutiny over flavored products creates offsetting risks. Investors should view today's dip as an opportunity to reassess PM's valuation following the dividend increase, while closely monitoring regulatory developments and the ultimate direction of the Trump administration's tobacco policy.
Benzinga · Sep 25, 2026
FDA commissioner nominee Heidi Overton faced grilling over vaccines, Trump's tobacco stock holdings and mifepristone safety at her Senate confirmation hearing.
Yahoo · Sep 24, 2026
“The current level of bond yields does not pose a threat to economic growth,” says Sonal Desai, global chief investment officer for Franklin Templeton Fixed Income.
Yahoo · Sep 24, 2026
Philip Morris (PM) could produce exceptional returns because of its solid growth attributes.
Yahoo · Sep 23, 2026
Investing.com -- The Trump administration is preparing a major regulatory shift to accelerate market authorization for smoke-free nicotine products, according to reporting by The Wall Street Journal. The Food and Drug Administration is expected to announce changes easing the requirements of its 2021 premarket review framework in coming days, establishing a streamlined regulatory pathway for alternative nicotine delivery systems. The regulatory overhaul aims to simplify scientific study standards
Interpretive context generated from the platform’s current data sources.
Philip Morris International Inc. shares traded at $191.50, reflecting a daily decline of 0.73% per SID market data. Despite the near-term pullback, the stock has demonstrated strong momentum over longer horizons, gaining 7.03% over the trailing three months and 21.24% over the past year. The 50-day moving average stands at $190.07, with PM trading slightly above that threshold, while the 200-day moving average of $179.88 indicates sustained upward trajectory over the medium term. The 14-day relative strength index registers at 59.7, placing the stock in neutral territory without overbought or oversold signals. PM's beta of 0.436, according to Massive/Polygon data, confirms significantly lower volatility relative to the broader market, consistent with its Consumer Defensive sector classification. Average daily trading volume stands at approximately 6.58 million shares, supporting adequate liquidity for institutional positioning. The company's market capitalization sits at approximately $234.96 billion.
Philip Morris International carries a price-to-earnings ratio of 27.29, per SID market data, positioning it at a premium relative to many Consumer Defensive peers. The PEG ratio of 5.76 suggests that the current earnings multiple significantly exceeds the company's projected growth rate, indicating limited growth-adjusted value at present price levels. Notably, PM reports a negative price-to-book ratio of -21.53, according to SEC filings, reflecting a negative book value driven by accumulated share repurchases and significant leverage on the balance sheet — a structural characteristic common among capital-return-focused tobacco companies. The stock offers a dividend yield of 3.66%, providing meaningful income for shareholders and reinforcing its appeal within defensive equity allocations. With a market capitalization of approximately $234.96 billion, Philip Morris remains one of the largest companies in the global tobacco and nicotine sector. These valuation metrics collectively reflect a mature, cash-generative business trading at elevated earnings multiples.
Philip Morris International registers a composite smart money score of 58, per SID market data, signaling a neutral overall positioning among sophisticated market participants. Institutional activity scores a perfect 25 out of 25, indicating maximum conviction from large asset managers and fund complexes, according to 13F institutional filings. This robust institutional presence aligns with PM's status as a mega-cap defensive holding widely represented in dividend and income-oriented portfolios. Insider activity scores 12.5 out of 25, reflecting moderate engagement from corporate executives and directors based on SEC Form 4 filings, without signaling either strong accumulation or notable distribution. Congressional trading activity registers at 12 out of 25, suggesting limited but present interest from lawmakers in their disclosed transactions. Dark pool activity scores 8.5 out of 25, indicating relatively subdued off-exchange trading volume. The divergence between the maximum institutional score and lower dark pool activity suggests that large holders are maintaining established positions rather than actively building or reducing exposure through alternative venues.
Philip Morris International has delivered consecutive positive earnings surprises in its two most recently reported quarters, according to company earnings reports. In the quarter reported on April 22, 2026, PM posted earnings per share of $1.96 against a consensus estimate of $1.82, representing a positive surprise of $0.14 or approximately 7.7%. The subsequent quarter reported on July 22, 2026, showed further outperformance with actual EPS of $2.20 versus the $2.05 estimate, delivering a $0.15 beat. Analyst estimates project EPS of $2.05 for the quarter with results expected on July 21, 2026, and $2.34 for the quarter scheduled for October 20, 2026. The upward progression in estimates reflects anticipated growth driven by the company's expanding heated tobacco and smoke-free product portfolio. The consistent pattern of exceeding expectations by meaningful margins suggests that consensus forecasts may continue to underestimate Philip Morris's earnings power in upcoming periods.
Wall Street analyst sentiment toward Philip Morris International remains broadly constructive, per SID consensus data. Among the five most recent ratings, four reflect bullish designations. Citigroup reiterated a Buy rating on July 30, 2026, while Barclays maintained an Overweight call on July 29, 2026, according to Wall Street analyst reports. Morgan Stanley and Stifel both reaffirmed Overweight and Buy ratings respectively on July 23, 2026, immediately following the company's earnings release that delivered a $0.15 positive surprise. UBS represents the sole neutral voice, maintaining its Neutral rating as of September 23, 2026. Notably, none of the recent analyst actions involved downgrades or target reductions; each reiteration maintained the prior rating classification unchanged. This uniformity in maintaining existing ratings suggests that PM's fundamental trajectory continues to meet or exceed institutional expectations. The concentration of positive reaffirmations following the July earnings report indicates that the company's operational execution and smoke-free product growth strategy are resonating with the sell-side research community.
The latest Smart Investors Daily articles mentioning PM.
